11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice.
about
Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and AtherosclerosisModulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceVirtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid actionThe aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitisMineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature.Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP miceEndothelial glucocorticoid receptor suppresses atherogenesis--brief reportLow-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female MiceGenetic basis of atherosclerosis: insights from mice and humansMineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography.11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.Mineralocorticoid receptors in vascular function and disease.Eplerenone for the treatment of cardiovascular disorders.Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.Molecular biology of atherosclerosis.Mineralocorticoid receptor: a critical player in vascular remodeling.Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice.Auto-amplification of cortisol actions in human carotid atheroma is linked to arterial remodeling and stroke.Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study.
P2860
Q26781416-83261557-C956-44D7-BF8D-FE1E5E36C533Q26998660-7E8165F0-2CB7-4D04-A97A-194A5D31151AQ27322801-664DB9AD-7956-4328-9DD1-663CB6BFC50CQ28484229-B7238344-7FD0-477F-9F2E-0331E5CE166EQ28578431-7CECA393-1156-4B7B-915F-71CF0C90AB5DQ34381424-27031D7C-BC0C-4604-9D07-6072E9158726Q34483976-8C193C51-C2CC-42A5-9D3A-4BD56A7C7521Q34684861-6C6BB294-8F1C-430C-B5B4-C1CC401D1819Q34744777-EABD8F76-A673-4654-BE2B-BCACB7C95899Q35222164-E9A8E5D8-0550-4385-AD82-A3864B0137C4Q35738015-5B7549EC-1B30-4907-8111-54C5D0B6EA4FQ35975437-A5B55095-D54C-4A9A-8B85-A1A399B7FFF8Q36560643-494DD286-27BF-4636-9684-017CE182C382Q36701794-426DC93A-53DF-48D5-A5D0-241B086B7142Q36710876-692766AA-A9D2-4020-AB92-3EE373A1DB24Q36817194-8F723FC8-2E05-44F0-80D1-B869F797522DQ37655884-EAABBB43-6DB4-41FC-AABE-F4B13DCD369CQ37687150-DBEA4627-797A-4AAD-9064-2F5A618F3957Q37896953-C2C53F3A-7822-4B29-AC2F-7CECD2DA45DEQ38036328-901B009E-04C0-499C-99E5-DFF4527EE477Q38084054-F74B36E4-4611-4DA2-A62D-A1D3471878EDQ38103479-5450A62B-114C-4CBC-91FD-C3FE631E5E80Q38125279-F7CDAAF1-583E-4324-932E-D20637E14B67Q38238028-E4821BEB-7798-40A5-B3BA-EFBE048AF831Q39191329-49E76FC2-915A-4FBD-AF5E-F46D4A4B190EQ42040916-521210AE-8D27-4CED-875A-1B700D4A64EDQ45158054-21741181-73DB-4478-BD8C-986D85C516B0Q46664468-563480DF-00F9-44AB-92A4-00584819C1C3Q47304913-464350B9-764F-49A5-B60E-29595560B2CFQ54935905-49DA667A-DA60-4DF0-92BF-B42BF091ECB5
P2860
11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@en
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@nl
type
label
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@en
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@nl
prefLabel
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@en
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@nl
P2093
P2860
P356
P1433
P1476
11β-hydroxysteroid dehydrogena ...... e endothelium in apoe-/- mice.
@en
P2093
Danielle McLean
David G Brownstein
David J Webb
Graeme A Deuchar
John J Mullins
Jonathan R Seckl
Patrick W F Hadoke
Yuri V Kotelevtsev
P2860
P304
P356
10.1210/EN.2010-0925
P407
P577
2010-11-24T00:00:00Z